Tesamorelin

What the research on Tesamorelin has looked at

• Tesamorelin and fat around the organs: in a six-month trial, deep abdominal fat fell by an average of 34 square centimetres in the treated group while it rose by 8 in the placebo group
• Tesamorelin and fat in the liver: in a 12-month trial of 61 people, liver fat fell by 37% from where it started, against placebo
• Tesamorelin and clearing the liver-fat threshold: after 12 months, 35% of the treated group had liver fat below 5%, against 4% of the placebo group
• Tesamorelin and waist size: in a separate six-month trial, waists in the treated group shrank by 2.7 centimetres more than in the comparison group
• Tesamorelin and how it differs from its relatives: it is the full 44-link hormone, where sermorelin and CJC-1295 are the first 29 links only